Unicycive Therapeutics In...

NASDAQ: UNCY · Real-Time Price · USD
4.71
0.08 (1.73%)
At close: Aug 15, 2025, 3:59 PM
4.72
0.32%
After-hours: Aug 15, 2025, 07:57 PM EDT

Unicycive Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-36.73M -30.54M -18.06M -10.02M
Depreciation & Amortization
428K 284K 161K 13K
Stock-Based Compensation
2.35M 1.77M 1.05M 966K
Other Working Capital
-1.22M -1.37M -89K -1.35M
Other Non-Cash Items
5.8M 10.3M 21K 3.25M
Deferred Income Tax
n/a n/a n/a 127K
Change in Working Capital
-427K -93K 1.18M -105K
Operating Cash Flow
-28.57M -18.28M -15.65M -5.77M
Capital Expenditures
-72K -12K -2K -29K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-72K -12K -2K -29K
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
-1.09M n/a n/a n/a
Other Financial Acitivies
-4.5M -2.65M -482K 22.38M
Financial Cash Flow
45.09M 27.54M -471K 22.38M
Net Cash Flow
16.44M 9.25M -16.12M 16.58M
Free Cash Flow
-28.65M -18.3M -15.65M -5.8M